Meet the investigator: Daniel D. Billadeau, Ph.D.
At the Mayo Clinic Cancer Center, hundreds of researchers dedicate their professional lives to reducing the burden of cancer. Each one has a unique story. In this issue, Daniel D. Billadeau, Ph.D., an oncology researcher at Mayo Clinic in Rochester, Minnesota, talks about his work investigating pancreatic cancer. Dr. Billadeau is also a principal investigator of the Mayo Clinic Pancreatic Cancer SPORE.
Related
This article was originally published in Forefront, Mayo Clinic Cancer Center's online magazine, which ceased publication in December 2020.
Related Posts

Pancreatic cancer survivor Judy Ethen and others with a family history of the disease are helping researchers create ways to detect pancreatic cancer at an early stage when it can be cured.

Quick access to laboratory test results help pancreatic cancer survivor Jim Smith overcome anxiety about cancer recurrence.

Surgical oncologist Dr. Mark Truty wants people with pancreatic cancer to know there are more treatment options available than ever before.